AMERICAN THORACIC SOCIETY CONGRESS 2019
17-22 May | Dallas, Texas
Dallas Texas was the destination for the 2019 ATS International Conference (May 17th- 22nd). It brought together thousands of clinicians and researchers to learn, engage, and collaborate on the latest scientific findings, research, and innovation in respiratory medicine.
To watch GSK's daily highlights from this years congress please click on the videos below:
ATS 2019: Day 1 Video Highlight, Breaking the paradigm: early origins of COPD (Professor Paul Jones)
ATS 2019: Day 1 Video Highlight, Treating Asthma in patients with Obesity (Professor Norbert Berend)
ATS 2019: Day 1 Video Highlight, Clinical Year in Review: COPD (Professor Christopher Cooper)
ATS 2019: Day 2 Video Highlight, 50 Years of Progress in Pulmonary Science (Neil Barnes)
ATS 2019: Day 3 Video Highlight, Evidence in Asthma and COPD Overlap (Ronald Dahl)
Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971, firstname.lastname@example.org. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Trade marks are owned by or licensed to the GSK group of companies.